Junttila et al (2007) have suggested that CIP2A expression is already induced in premalignant head and neck squamous cell carcinoma tissue in response to a combination of oncogenic Ras signalling with inhibition of the TGF-β tumour suppressor pathway. This evidence concerns the gene CIP2A and head and neck squamous cell carcinoma.